Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Hong Kong Pharma Digital Technology Holdings Limited (HKPD)

Compare
1.2000
-0.0700
(-5.51%)
At close: 4:00:00 PM EDT
Loading Chart for HKPD
  • Previous Close 1.2700
  • Open 1.2900
  • Bid 1.1400 x 100
  • Ask 1.2300 x 100
  • Day's Range 1.1101 - 1.2900
  • 52 Week Range 1.0000 - 3.7900
  • Volume 127,773
  • Avg. Volume 229,155
  • Market Cap (intraday) 13.2M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 7.06
  • EPS (TTM) 0.1700
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the OTC pharmaceutical business in Hong Kong and Mainland China. It provides OTC pharmaceutical cross-border e-commerce supply chain; and procurement and distribution services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. Hong Kong Pharma Digital Technology Holdings Limited was incorporated in 2023 and is based in Yau Tong, Hong Kong.

www.9zt.hk

19

Full Time Employees

March 31

Fiscal Year Ends

Recent News: HKPD

View More

Performance Overview: HKPD

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HKPD
65.71%
S&P 500 (^GSPC)
8.25%

1-Year Return

HKPD
65.71%
S&P 500 (^GSPC)
6.61%

3-Year Return

HKPD
65.71%
S&P 500 (^GSPC)
22.86%

5-Year Return

HKPD
65.71%
S&P 500 (^GSPC)
93.89%

Compare To: HKPD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HKPD

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    13.97M

  • Enterprise Value

    15.95M

  • Trailing P/E

    7.32

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.67

  • Price/Book (mrq)

    2.61

  • Enterprise Value/Revenue

    0.77

  • Enterprise Value/EBITDA

    4.91

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.19%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    20.77M

  • Net Income Avi to Common (ttm)

    1.91M

  • Diluted EPS (ttm)

    0.1700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    364.99k

  • Total Debt/Equity (mrq)

    43.88%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: HKPD

View More

Company Insights: HKPD

Research Reports: HKPD

View More

People Also Watch